SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-001017
Filing Date
2017-01-06
Accepted
2017-01-06 17:13:53
Documents
1
Period of Report
2016-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6610
  Complete submission text file 0001140361-17-001017.txt   7982
Mailing Address C/O INVIVO THERAPEUTICS HOLDING CORP. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Wirth Edward (Reporting) CIK: 0001532558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36646 | Film No.: 17515036

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Issuer) CIK: 0001572552 (see all company filings)

IRS No.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1